KUWAIT CITY, May 25: Dr. Ghanem Al-Hujailan, a consultant for internal and epidemiological diseases at the Adan Hospital, warned of the emergence of strains resistant to COVID- 19 vaccination due to the delay in administering the second dose of the Oxford-AstraZeneca vaccine, which for some has exceeded more than three months since their first dose. This is in relation to the plan prepared by the Ministry of Health to vaccinate those waiting for the second dose of the Oxford vaccine within the coming two weeks after receiving lab efficacy tests of the Oxford-AstraZeneca shipment that has arrived in Kuwait.
In a press statement, Dr. Al-Hujailan said, “Many of these people were infected with the virus during this period. This foreshadows the emergence of vaccine-resistant strains. A single dose does not give complete protection for the body.” He revealed that the number of those vaccinated with the Oxford vaccine in Kuwait as of March 22 is about 500,000, and these people could be infected with COVID-19 virus as a result of decrease in the immunity to the virus over time. Dr. Al-Hujailan reassured that there are no cases of black fungus in Kuwait, explaining that this fungus is opportunistic in nature, as it takes advantage of the patient’s long periods of stay in the intensive care unit, and their consumption of large quantities of antibiotics and cortisone over long periods. By Marwa Al-Bahrawi Al-Seyassah and Arab Times Staff